000			01996 a2200577 4500
005			20250515073520.0
264		0	_c20070928
008			200709s 0 0 eng d
022			_a0007-1048
024	7		_a10.1111/j.1365-2141.2007.06684.x _2doi
040			_aNLM _beng _cNLM
100	1		_aDang, Nam H
245	0	0	_aPhase II trial of the combination of denileukin diftitox and rituximab for relapsed/refractory B-cell non-Hodgkin lymphoma. _h[electronic resource]
260			_bBritish journal of haematology _cAug 2007
300			_a502-5 p. _bdigital
500			_aPublication Type: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aAntibodies, Monoclonal _xtherapeutic use
650	0	4	_aAntibodies, Monoclonal, Murine-Derived
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use
650	0	4	_aDiphtheria Toxin _xtherapeutic use
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aInterleukin-2 _xtherapeutic use
650	0	4	_aLymphoma, B-Cell _xdrug therapy
650	0	4	_aLymphoma, Follicular _xdrug therapy
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aNeoplasm Staging
650	0	4	_aRecombinant Fusion Proteins _xtherapeutic use
650	0	4	_aRecurrence
650	0	4	_aRituximab
650	0	4	_aTime Factors
650	0	4	_aTreatment Outcome
700	1		_aFayad, Luis
700	1		_aMcLaughlin, Peter
700	1		_aRomaguara, Jorge E
700	1		_aHagemeister, Fredrick
700	1		_aGoy, Andre
700	1		_aNeelapu, Sattva
700	1		_aSamaniego, Felipe
700	1		_aWalker, Pamela L
700	1		_aWang, Michael
700	1		_aRodriguez, Maria A
700	1		_aTong, Ann T
700	1		_aPro, Barbara
773	0		_tBritish journal of haematology _gvol. 138 _gno. 4 _gp. 502-5
856	4	0	_uhttps://doi.org/10.1111/j.1365-2141.2007.06684.x _zAvailable from publisher's website
999			_c17144842 _d17144842